CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 101 enrolled
Drug / intervention
Woebot-SUDs (W-SUDs)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04096001
NCT04096001Phase 1Completed
CompareCT.gov

RCT of Woebot for Substance Use Disorders Phase 1

Woebot Health·interventional·Posted Sep 19, 2019·Updated Aug 31, 2022

In Brief

A Phase 1 clinical trial evaluating Woebot-SUDs (W-SUDs) for Substance Use Disorders. Completed, enrolled 101 participants across 1 site.

Detailed Summary

Phase 1 of this study aims to develop a digitally-delivered substance use disorder program through the Woebot app-based platform (W-SUDs) and evaluate the effectiveness of, patient satisfaction with and the acceptability of W-SUDs as a substance use management tool.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubstance Use Disorders
CountriesUnited States
CollaboratorsStanford University

Timeline

Phase 1CompletedFinished
2020202120222023202420252026
First PostedSep 19, 2019
Enrollment StartMar 26, 2020
Primary CompletionAug 31, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.8 years ago

Interventions

Woebot-SUDs (W-SUDs)device

Woebot-SUDs (W-SUDS), an artificially intelligence-powered conversational agent on a smartphone app, eliminates most current SUDs treatment barriers while simultaneously leveraging technology to enhance user experience and engagement. W-SUDs expands and refines existing SUDs treatments by adapting skills from cognitive behavioral therapy, motivational interviewing, and dialectical behavior therapy.